Keywords
Last Name
Institution

Jaime Uribarri

TitlePROFESSOR
InstitutionMount Sinai
DepartmentNephrology
Address5 East 98th Street
11th Floor
New York NY 10029
Phone212-241-4060
Fax212-987-0389

     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Schulman CI, Uribarri J, Cai W, Manning R, Landy DC, Gallardo M, Castillo A, Namias N, Striker GE, Livingstone A, Vlassara H. Increased circulating advanced glycation endproducts (AGEs) in acute trauma patients. Clin Chem Lab Med. 2014 Jan 1; 52(1):103-8.
      View in: PubMed
    2. Vlassara H, Uribarri J. Advanced Glycation End Products (AGE) and Diabetes: Cause, Effect, or Both? Curr Diab Rep. 2014 Jan; 14(1):453.
      View in: PubMed
    3. Sanghavi S, Whiting S, Uribarri J. Potassium balance in dialysis patients. Semin Dial. 2013 Sep-Oct; 26(5):597-603.
      View in: PubMed
    4. Uribarri J, Calvo MS. Dietary phosphorus excess: a risk factor in chronic bone, kidney, and cardiovascular disease? Adv Nutr. 2013 Sep; 4(5):542-4.
      View in: PubMed
    5. Calvo MS, Uribarri J. Public health impact of dietary phosphorus excess on bone and cardiovascular health in the general population. Am J Clin Nutr. 2013 Jul; 98(1):6-15.
      View in: PubMed
    6. Baber U, Bander J, Karajgikar R, Yadav K, Hadi A, Theodoropolous K, Gukathasan N, Roy S, Sayeneni S, Scott SA, Kovacic JC, Yu J, Sartori S, Mehran R, Uribarri J, Badimon JJ, Muntner P, Moreno P, Kini AS, Sharma SK. Combined and independent impact of diabetes mellitus and chronic kidney disease on residual platelet reactivity. Thromb Haemost. 2013 Jul; 110(1):118-23.
      View in: PubMed
    7. Calvo MS, Uribarri J. Contributions to total phosphorus intake: all sources considered. Semin Dial. 2013 Jan-Feb; 26(1):54-61.
      View in: PubMed
    8. Vlassara H, Cai W, Chen X, Serrano EJ, Shobha MS, Uribarri J, Woodward M, Striker GE. Managing chronic inflammation in the aging diabetic patient with CKD by diet or sevelamer carbonate: a modern paradigm shift. J Gerontol A Biol Sci Med Sci. 2012 Dec; 67(12):1410-6.
      View in: PubMed
    9. Mallipattu SK, He JC, Uribarri J. Role of advanced glycation endproducts and potential therapeutic interventions in dialysis patients. Semin Dial. 2012 Sep-Oct; 25(5):529-38.
      View in: PubMed
    10. Vlassara H, Uribarri J, Cai W, Goodman S, Pyzik R, Post J, Grosjean F, Woodward M, Striker GE. Effects of sevelamer on HbA1c, inflammation, and advanced glycation end products in diabetic kidney disease. Clin J Am Soc Nephrol. 2012 Jun; 7(6):934-42.
      View in: PubMed
    11. Uribarri J, Oh MS. The key to halting progression of CKD might be in the produce market, not in the pharmacy. Kidney Int. 2012 Jan; 81(1):7-9.
      View in: PubMed
    12. Beeri MS, Moshier E, Schmeidler J, Godbold J, Uribarri J, Reddy S, Sano M, Grossman HT, Cai W, Vlassara H, Silverman JM. Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individuals. Mech Ageing Dev. 2011 Nov-Dec; 132(11-12):583-7.
      View in: PubMed
    13. Uribarri J, Cai W, Ramdas M, Goodman S, Pyzik R, Chen X, Zhu L, Striker GE, Vlassara H. Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1. Diabetes Care. 2011 Jul; 34(7):1610-6.
      View in: PubMed
    14. Sawinski D, Uribarri J, Peace D, Yao T, Wauhop P, Trzcinka P, Ostrow K, Poggio ED, Heeger PS. 25-OH-vitamin D deficiency and cellular alloimmunity as measured by panel of reactive T cell testing in dialysis patients. Am J Transplant. 2010 Oct; 10(10):2287-95.
      View in: PubMed
    15. Mericq V, Piccardo C, Cai W, Chen X, Zhu L, Striker GE, Vlassara H, Uribarri J. Maternally transmitted and food-derived glycotoxins: a factor preconditioning the young to diabetes? Diabetes Care. 2010 Oct; 33(10):2232-7.
      View in: PubMed
    16. Uribarri J, Woodruff S, Goodman S, Cai W, Chen X, Pyzik R, Yong A, Striker GE, Vlassara H. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc. 2010 Jun; 110(6):911-16.e12.
      View in: PubMed
    17. Vlassara H, Torreggiani M, Post JB, Zheng F, Uribarri J, Striker GE. Role of oxidants/inflammation in declining renal function in chronic kidney disease and normal aging. Kidney Int Suppl. 2009 Dec; (114):S3-11.
      View in: PubMed
    18. Vlassara H, Uribarri J, Ferrucci L, Cai W, Torreggiani M, Post JB, Zheng F, Striker GE. Identifying advanced glycation end products as a major source of oxidants in aging: implications for the management and/or prevention of reduced renal function in elderly persons. Semin Nephrol. 2009 Nov; 29(6):594-603.
      View in: PubMed
    19. Vlassara H, Cai W, Goodman S, Pyzik R, Yong A, Chen X, Zhu L, Neade T, Beeri M, Silverman JM, Ferrucci L, Tansman L, Striker GE, Uribarri J. Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGE receptor-1. J Clin Endocrinol Metab. 2009 Nov; 94(11):4483-91.
      View in: PubMed
    20. Uribarri J. Phosphorus additives in food and their effect in dialysis patients. Clin J Am Soc Nephrol. 2009 Aug; 4(8):1290-2.
      View in: PubMed
    21. Muntner P, Vupputuri S, Coresh J, Uribarri J, Fox CS. Metabolic abnormalities are present in adults with elevated serum cystatin C. Kidney Int. 2009 Jul; 76(1):81-8.
      View in: PubMed
    22. de la Maza MP, Uribarri J, Olivares D, Hirsch S, Leiva L, Barrera G, Bunout D. Weight increase is associated with skeletal muscle immunostaining for advanced glycation end products, receptor for advanced glycation end products, and oxidation injury. Rejuvenation Res. 2008 Dec; 11(6):1041-8.
      View in: PubMed
    23. Neade T, Uribarri J. Diet, inflammation, and chronic kidney disease: getting to the heart of the matter. Semin Dial. 2008 Jul-Aug; 21(4):331-7.
      View in: PubMed
    24. Melamed ML, Muntner P, Michos ED, Uribarri J, Weber C, Sharma J, Raggi P. Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler Thromb Vasc Biol. 2008 Jun; 28(6):1179-85.
      View in: PubMed
    25. Muntner P, Winston J, Uribarri J, Mann D, Fox CS. Overweight, obesity, and elevated serum cystatin C levels in adults in the United States. Am J Med. 2008 Apr; 121(4):341-8.
      View in: PubMed
    26. Vassalotti JA, Uribarri J, Chen SC, Li S, Wang C, Collins AJ, Calvo MS, Whaley-Connell AT, McCullough PA, Norris KC. Trends in mineral metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis. 2008 Apr; 51(4 Suppl 2):S56-68.
      View in: PubMed
    27. Vlassara H, Uribarri J, Cai W, Striker G. Advanced glycation end product homeostasis: exogenous oxidants and innate defenses. Ann N Y Acad Sci. 2008 Apr; 1126:46-52.
      View in: PubMed
    28. Peppa M, Uribarri J, Vlassara H. Aging and glycoxidant stress. Hormones (Athens). 2008 Apr-Jun; 7(2):123-32.
      View in: PubMed
    29. Stirban A, Negrean M, Götting C, Uribarri J, Gawlowski T, Stratmann B, Kleesiek K, Koschinsky T, Vlassara H, Tschoepe D. Dietary advanced glycation endproducts and oxidative stress: in vivo effects on endothelial function and adipokines. Ann N Y Acad Sci. 2008 Apr; 1126:276-9.
      View in: PubMed
    30. Uribarri J. How should dialysis fluid be individualized for the chronic hemodialysis patient? Bicarbonate. Semin Dial. 2008 May-Jun; 21(3):221-3.
      View in: PubMed
    31. Linden E, Cai W, He JC, Xue C, Li Z, Winston J, Vlassara H, Uribarri J. Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation. Clin J Am Soc Nephrol. 2008 May; 3(3):691-8.
      View in: PubMed
    32. Chuang PY, Yu Q, Fang W, Uribarri J, He JC. Advanced glycation endproducts induce podocyte apoptosis by activation of the FOXO4 transcription factor. Kidney Int. 2007 Oct; 72(8):965-76.
      View in: PubMed
    33. Uribarri J. Phosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intake. Semin Dial. 2007 Jul-Aug; 20(4):295-301.
      View in: PubMed
    34. Uribarri J, Stirban A, Sander D, Cai W, Negrean M, Buenting CE, Koschinsky T, Vlassara H. Single oral challenge by advanced glycation end products acutely impairs endothelial function in diabetic and nondiabetic subjects. Diabetes Care. 2007 Oct; 30(10):2579-82.
      View in: PubMed
    35. Negrean M, Stirban A, Stratmann B, Gawlowski T, Horstmann T, Götting C, Kleesiek K, Mueller-Roesel M, Koschinsky T, Uribarri J, Vlassara H, Tschoepe D. Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus. Am J Clin Nutr. 2007 May; 85(5):1236-43.
      View in: PubMed
    36. Prohovnik I, Post J, Uribarri J, Lee H, Sandu O, Langhoff E. Cerebrovascular effects of hemodialysis in chronic kidney disease. J Cereb Blood Flow Metab. 2007 Nov; 27(11):1861-9.
      View in: PubMed
    37. Uribarri J, Cai W, Peppa M, Goodman S, Ferrucci L, Striker G, Vlassara H. Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. J Gerontol A Biol Sci Med Sci. 2007 Apr; 62(4):427-33.
      View in: PubMed
    38. Beeri MS, Uribarri J, Schmeidler J, Lally R, Wang J, Grossman HT, Langhoff E, Rosendorff C, Silverman JM. Normal homocysteine levels in well-functioning oldest-old individuals despite low kidney function. J Am Geriatr Soc. 2006 Oct; 54(10):1623-5.
      View in: PubMed
    39. Uribarri J, Tuttle KR. Advanced glycation end products and nephrotoxicity of high-protein diets. Clin J Am Soc Nephrol. 2006 Nov; 1(6):1293-9.
      View in: PubMed
    40. Peppa M, Brem H, Cai W, Zhang JG, Basgen J, Li Z, Vlassara H, Uribarri J. Prevention and reversal of diabetic nephropathy in db/db mice treated with alagebrium (ALT-711). Am J Nephrol. 2006; 26(5):430-6.
      View in: PubMed
    41. Stirban A, Negrean M, Stratmann B, Gawlowski T, Horstmann T, Götting C, Kleesiek K, Mueller-Roesel M, Koschinsky T, Uribarri J, Vlassara H, Tschoepe D. Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes. Diabetes Care. 2006 Sep; 29(9):2064-71.
      View in: PubMed
    42. Liu H, Zheng F, Li Z, Uribarri J, Ren B, Hutter R, Tunstead JR, Badimon J, Striker GE, Vlassara H. Reduced acute vascular injury and atherosclerosis in hyperlipidemic mice transgenic for lysozyme. Am J Pathol. 2006 Jul; 169(1):303-13.
      View in: PubMed
    43. Cai W, Zhu L, Chen X, Uribarri J, Peppa M. Association of advanced glycoxidation end products and inflammation markers with thrombosis of arteriovenous grafts in hemodialysis patients. Am J Nephrol. 2006; 26(2):181-5.
      View in: PubMed
    44. Sherer DW, Singer G, Uribarri J, Phelps RG, Sapadin AN, Freund KB, Yanuzzi L, Fuchs W, Lebwohl M. Oral phosphate binders in the treatment of pseudoxanthoma elasticum. J Am Acad Dermatol. 2005 Oct; 53(4):610-5.
      View in: PubMed
    45. Sandu O, Song K, Cai W, Zheng F, Uribarri J, Vlassara H. Insulin resistance and type 2 diabetes in high-fat-fed mice are linked to high glycotoxin intake. Diabetes. 2005 Aug; 54(8):2314-9.
      View in: PubMed
    46. Cohen E, Uribarri J. Cinacalcet cost and utility in dialysis patients. Semin Dial. 2005 Jul-Aug; 18(4):353-4.
      View in: PubMed
    47. Uribarri J, Cai W, Sandu O, Peppa M, Goldberg T, Vlassara H. Diet-derived advanced glycation end products are major contributors to the body's AGE pool and induce inflammation in healthy subjects. Ann N Y Acad Sci. 2005 Jun; 1043:461-6.
      View in: PubMed
    48. Uribarri J. K/DOQI guidelines for bone metabolism and disease in chronic kidney disease patients: some therapeutic implications. Semin Dial. 2004 Sep-Oct; 17(5):349-50.
      View in: PubMed
    49. Oh MS, Uribarri J, Weinstein J, Schreiber M, Kamel KS, Kraut JA, Madias NE, Laski ME. What unique acid-base considerations exist in dialysis patients? Semin Dial. 2004 Sep-Oct; 17(5):351-64.
      View in: PubMed
    50. Vlassara H, Uribarri J. Glycoxidation and diabetic complications: modern lessons and a warning? Rev Endocr Metab Disord. 2004 Aug; 5(3):181-8.
      View in: PubMed
    51. Goldberg T, Cai W, Peppa M, Dardaine V, Baliga BS, Uribarri J, Vlassara H. Advanced glycoxidation end products in commonly consumed foods. J Am Diet Assoc. 2004 Aug; 104(8):1287-91.
      View in: PubMed
    52. Cai W, He JC, Zhu L, Peppa M, Lu C, Uribarri J, Vlassara H. High levels of dietary advanced glycation end products transform low-density lipoprotein into a potent redox-sensitive mitogen-activated protein kinase stimulant in diabetic patients. Circulation. 2004 Jul 20; 110(3):285-91.
      View in: PubMed
    53. Peppa M, Uribarri J, Cai W, Lu M, Vlassara H. Glycoxidation and inflammation in renal failure patients. Am J Kidney Dis. 2004 Apr; 43(4):690-5.
      View in: PubMed
    54. Vassalotti JA, Falk A, Teodorescu V, Uribarri J. The multidisciplinary approach to hemodialysis vascular access at the Mount Sinai Hospital. Mt Sinai J Med. 2004 Mar; 71(2):94-102.
      View in: PubMed
    55. Peppa M, Uribarri J, Vlassara H. The role of advanced glycation end products in the development of atherosclerosis. Curr Diab Rep. 2004 Feb; 4(1):31-6.
      View in: PubMed
    56. Uribarri J, Prabhakar S, Kahn T. Hyponatremia in peritoneal dialysis patients. Clin Nephrol. 2004 Jan; 61(1):54-8.
      View in: PubMed
    57. Oder TF, Teodorescu V, Uribarri J. Effect of exercise on the diameter of arteriovenous fistulae in hemodialysis patients. ASAIO J. 2003 Sep-Oct; 49(5):554-5.
      View in: PubMed
    58. Uribarri J, Peppa M, Cai W, Goldberg T, Lu M, Baliga S, Vassalotti JA, Vlassara H. Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients. Am J Kidney Dis. 2003 Sep; 42(3):532-8.
      View in: PubMed
    59. Uribarri J, Calvo MS. Hidden sources of phosphorus in the typical American diet: does it matter in nephrology? Semin Dial. 2003 May-Jun; 16(3):186-8.
      View in: PubMed
    60. Uribarri J, Peppa M, Cai W, Goldberg T, Lu M, He C, Vlassara H. Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients. J Am Soc Nephrol. 2003 Mar; 14(3):728-31.
      View in: PubMed
    61. Caplin N, Sedlacek M, Teodorescu V, Falk A, Uribarri J. Venous access: women are equal. Am J Kidney Dis. 2003 Feb; 41(2):429-32.
      View in: PubMed
    62. Block G, Uribarri J, Coladonato JA, Fan SL, Cunningham J, Nolan CR, Qunibi WY, Lindberg JS. How should hyperphosphatemia be managed in dialysis patients? Semin Dial. 2002 Sep-Oct; 15(5):315-28.
      View in: PubMed
    63. Uribarri J. Unrecognized sources of dietary phosphate. Semin Dial. 2002 Sep-Oct; 15(5):376.
      View in: PubMed
    64. Vassalotti JA, Falk A, Cohl ED, Uribarri J, Teodorescu V. Obese and non-obese hemodialysis patients have a similar prevalence of functioning arteriovenous fistula using pre-operative vein mapping. Clin Nephrol. 2002 Sep; 58(3):211-4.
      View in: PubMed
    65. Ifudu O, Uribarri J, Rajwani I, Vlacich V, Reydel K, Delosreyes G, Friedman EA. Relation between interdialytic weight gain, body weight and nutrition in hemodialysis patients. Am J Nephrol. 2002 Jul-Aug; 22(4):363-8.
      View in: PubMed
    66. He C, Charoenkul V, Kahn T, Langhoff E, Uribarri J, Sedlacek M. Impact of the surgeon on the prevalence of arteriovenous fistulas. ASAIO J. 2002 Jan-Feb; 48(1):39-40.
      View in: PubMed
    67. Peppa M, Uribarri J, Vlassara H. Advanced glycoxidation. A new risk factor for cardiovascular disease? Cardiovasc Toxicol. 2002; 2(4):275-87.
      View in: PubMed
    68. Uribarri J. Doqi guidelines for nutrition in long-term peritoneal dialysis patients: a dissenting view. Am J Kidney Dis. 2001 Jun; 37(6):1313-8.
      View in: PubMed
    69. Sedlacek M, Dimaano F, Uribarri J. Relationship between phosphorus and creatinine clearance in peritoneal dialysis: clinical implications. Am J Kidney Dis. 2000 Nov; 36(5):1020-4.
      View in: PubMed
    70. Uribarri J. The obsession with high dietary protein intake in ESRD patients on dialysis: is it justified? Nephron. 2000 Oct; 86(2):105-8.
      View in: PubMed
    71. Korosi A, Kahn T, Kalb T, Uribarri J. Marked hyperlactatemia associated with severe alkalemia in a patient with thrombotic thrombocytopenic purpura. Am J Kidney Dis. 2000 Jul; 36(1):E6.
      View in: PubMed
    72. Uribarri J. Acidosis in chronic renal insufficiency. Semin Dial. 2000 Jul-Aug; 13(4):232-4.
      View in: PubMed
    73. Uribarri J, Levin NW, Delmez J, Depner TA, Ornt D, Owen W, Yan G. Association of acidosis and nutritional parameters in hemodialysis patients. Am J Kidney Dis. 1999 Sep; 34(3):493-9.
      View in: PubMed
    74. Marcus RG, Cohl E, Uribarri J. Protein intake seems to respond to increases in Kt/V despite baseline Kt/V greater than 1.2. Am J Nephrol. 1999; 19(4):500-4.
      View in: PubMed
    75. Uribarri J. Past, present and future of end-stage renal disease therapy in the United States. Mt Sinai J Med. 1999 Jan; 66(1):14-9.
      View in: PubMed
    76. Uribarri J, Leibowitz J, Dimaano F. Caloric intake in a group of peritoneal dialysis patients. Am J Kidney Dis. 1998 Dec; 32(6):1019-22.
      View in: PubMed
    77. Uribarri J, Oh MS, Pak CY. Renal stone risk factors in patients with type IV renal tubular acidosis. Am J Kidney Dis. 1994 Jun; 23(6):784-7.
      View in: PubMed
    78. Oh MS, Uribarri JV, Del Monte ML, Friedman EA, Carroll HJ. Consumpton of CO2 in metabolism of acetate as an explanation for hypoventilation and hypoxemia during hemodialysis. Proc Clin Dial Transplant Forum. 1979; 9:226-9.
      View in: PubMed
    Uribarri's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067